Patrys LimitedASX: PAB

PAT-DX1/Radiation Combination Improves Brain Cancer Survival

· Issued by Patrys Limited

Filed with ASX · · 4 pages · English

 Telethon Kids Cancer Centre has completed a new animal study in high grade glioma, finding that PAT-DX1 improves the efficacy of radiation therapy  In combination with a therapeutic dose of radiation, PAT-DX1 resulted in significantly prolonged survival compared to radiation alone, with 2 of 10 mice being long term survivors  Even below its optimal dose PAT-DX1 as a single agent increased surv

Patrys Limited on 6ix

Earlier from Patrys

Later from Patrys

All Patrys news releases